SANIGEN Co., Ltd. Logo

SANIGEN Co., Ltd.

Provides food safety solutions and genetic diagnostics for the entire food industry.

188260 | KO

Overview

Corporate Details

ISIN(s):
KR7188260004
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 흥안대로427번길 16, 411호, 안양시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

SANIGEN Co., Ltd. is a food safety and sanitation company that provides total solutions for the food industry, encompassing manufacturing, distribution, and sales. The company specializes in developing and manufacturing advanced diagnostic products based on microbial genetic analysis technologies, including Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS). Founded in 2005, Sanigen delivers innovative technologies and differentiated services aimed at establishing hygienic manufacturing environments and ensuring food safety, with a mission to protect human health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-08 00:00
Regulatory News Service
거래처와의거래중단
Korean 7.2 KB
2025-09-01 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 128.7 KB
2025-08-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-08-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 131.3 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.5 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.6 MB
2025-03-13 00:00
Audit Report / Information
감사보고서제출
Korean 18.5 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 6.4 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 5.0 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 170.2 KB
2025-03-06 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 100.2 KB
2025-02-13 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.1 KB
2025-02-13 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB

Automate Your Workflow. Get a real-time feed of all SANIGEN Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SANIGEN Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SANIGEN Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.